Eric M Wakshull

USPTO Granted Patents = 11 (Patent Applications = 1)

Average Co-Inventor Count = 4.5

ph-index = 7

Forward Citations = 127(Granted Patents)

Company Filing History:

5 out of 10

The Collaborative Group, Ltd.

Biopolymer Engineering Pharmaceutical, Inc.

patents

5. 1 out of 202

Elan Pharmaceuticals, Inc.

patents

where one patent can have more than one assignee

Years Active: 2000-2023

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11686734 - Methods and products for evaluating an immune response to a therapeutic protein (2023-06-27),

2. 10705095 - Methods and products for evaluating an immune response to a therapeutic protein (2020-07-07),

3. 9709575 - Methods and products for evaluating an immune response to a therapeutic protein (2017-07-18),

4. 8871449 - Methods and products for evaluating an immune response to a therapeutic protein (2014-10-28),

5. 8124350 - Methods and products for evaluating an immune response to a therapeutic protein (2012-02-28),

6. 6630310 - Assay for binding between carbohydrate and glycolipid (2003-10-07),

7. 6413715 - &bgr;(1-3)-glucan diagnostic assays (2002-07-02),

8. 6294321 - &bgr;(1-3)-glucan diagnostic assays (2001-09-25),

9. 6110692 - Receptor for underivatized aqueous soluble .beta.(1-3)-glucan (2000-08-29),

10. 6090938 - Activation of signal transduction by underivatized, aqueous soluble . (2000-07-18),

11. 6084092 - .beta.(1-3)-glucan diagnostic assays (2000-07-04),

Title: Exploring the Innovations of Inventor Eric M Wakshull

Introduction

Inventor Eric M Wakshull, hailing from Princeton, MA (US), has left a remarkable imprint in the realm of inventions with an impressive portfolio of 11 patents under his belt.

Latest Patents

Among his latest patents is the groundbreaking "Methods and products for evaluating an immune response to a therapeutic protein." This invention focuses on identifying clinically significant immune responses in patients treated with therapeutic proteins, particularly VLA4 binding antibodies like natalizumab.

Career Highlights

Eric M Wakshull’s career has been colored with significant contributions at companies like The Collaborative Group, Ltd., and Biogen MA Inc. His innovative spirit and dedication to advancing medical technologies have led to transformative solutions in the field.

Collaborations

Throughout his journey, Eric M Wakshull has collaborated with esteemed professionals such as William M Mackin and Janet W Zimmerman, synergizing their expertise to drive innovation forward.

Conclusion

In conclusion, Eric M Wakshull stands as a prominent figure in the world of inventions, continuously pushing the boundaries of what is possible in evaluating immune responses to therapeutic proteins. His impactful work serves as a testament to the power of innovation in shaping the future of healthcare.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

1 patent pending:

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.